KRAS‐mutated, ER‐positive low‐grade serous ovarian cancer: Unraveling an exceptional response mystery – Kato – – The Oncologist

Corresponding Author

Integrative Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA, USA

Equal contribution

Corresponding authors’ contact information: Shumei Kato, M.D. Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center 3855 Health Sciences Drive, La Jolla, CA 92093 Email: smkato@health.ucsd.edu Phone: 858‐822‐2372 FAX: 858‐822‐6186 Edward Stites, M.D., Ph.D. Integrative Biology Laboratory, Salk Institute for Biological Studies 10010 N Torrey Pines Rd, La Jolla, CA 92037 Email: estites@salk.eduSearch for more papers by this author